中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Transferrin Serves As a Mediator to Deliver Organometallic Ruthenium(II) Anticancer Complexes into Cells

文献类型:期刊论文

作者Guo, Wei; Zheng, Wei; Luo, Qun; Li, Xianchan; Zhao, Yao; Xiong, Shaoxiang; Wang, Fuyi
刊名INORGANIC CHEMISTRY
出版日期2013-05-06
卷号52期号:9页码:5328-5338
ISSN号0020-1669
DOI10.1021/ic4002626
英文摘要We report herein a systematic study on interactions of organometallic ruthenium(II) anticancer complex [(eta(6)-arene)Ru(en)Cl](+) (arene = p-cymene (1) or biphenyl (2), en = ethylenediamine) with human transferrin (hTf) and the effects of the hTf-ligation on the bioavailability of these complexes with cisplatin as a reference. Incubated with a 5-fold excess of complex 1, 2, or cisplatin, 1 mol of diferric hTf (holo-hTf) attached 0.62 mol of 1, 1.01 mol of 2, or 2.14 mol of cisplatin. Mass spectrometry revealed that both ruthenium complexes coordinated to N-donors His242, His273, His578, and His606, whereas cisplatin bound to 0 donors Tyr136 and Tyr317 and S-donor Met256 in addition to His273 and His578 on the surface of both apo- and holo-hTf. Moreover, cisplatin could bind to Thr457 within the C-lobe iron binding cleft of apo-hTf. Neither ruthenium nor platinum binding interfered with the recognition of holo-hTf by the transferrin receptor (TfR). The ruthenated/platinated holo-hTf complexes could be internalized via TfR-mediated endocytosis at a similar rate to that of holo-hTf itself. Moreover, the binding to holo-hTf well preserved the bioavailability of the ruthenium complexes, and the hTf-bound 1 and 2 showed a similar cytotoxicity toward the human breast cancer cell line MCF-7 to those of the complexes themselves. However, the conjugation with holo-hTf significantly reduced the cellular uptake of cisplatin and the amount of platinated DNA adducts formed intracellularly, leading to dramatic reduction of cisplatin cytotoxicity toward MCF-7. These findings suggest that hTf can serve as a mediator for the targeting delivery of Ru(arene) anticancer complexes while deactivating cisplatin.
语种英语
WOS记录号WOS:000318669400070
出版者AMER CHEMICAL SOC
源URL[http://ir.iccas.ac.cn/handle/121111/54661]  
专题中国科学院化学研究所
通讯作者Wang, Fuyi
作者单位Chinese Acad Sci, Beijing Ctr Mass Spectrometry, CAS Key Lab Analyt Chem Living Biosyst, Beijing Natl Lab Mol Sci,Inst Chem, Beijing 100190, Peoples R China
推荐引用方式
GB/T 7714
Guo, Wei,Zheng, Wei,Luo, Qun,et al. Transferrin Serves As a Mediator to Deliver Organometallic Ruthenium(II) Anticancer Complexes into Cells[J]. INORGANIC CHEMISTRY,2013,52(9):5328-5338.
APA Guo, Wei.,Zheng, Wei.,Luo, Qun.,Li, Xianchan.,Zhao, Yao.,...&Wang, Fuyi.(2013).Transferrin Serves As a Mediator to Deliver Organometallic Ruthenium(II) Anticancer Complexes into Cells.INORGANIC CHEMISTRY,52(9),5328-5338.
MLA Guo, Wei,et al."Transferrin Serves As a Mediator to Deliver Organometallic Ruthenium(II) Anticancer Complexes into Cells".INORGANIC CHEMISTRY 52.9(2013):5328-5338.

入库方式: OAI收割

来源:化学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。